Evaluation of reward from pain relief

Annals of the New York Academy of Sciences

Volumn 1282, Issue 1, 2013, Pages 1-11

  Navratilova, Edita ^a   Xie, Jennifer Yanhua ^a   King, Tamara ^b   Porreca, Frank ^a  

^a UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF NEW ENGLAND   (United States)

Author keywords

Conditioned place preference; Dopamine; Mesolimbic reward circuit; Operant behavior; Pain affect; Spontaneous pain

Indexed keywords

CLONIDINE; DICLOFENAC; LIDOCAINE; N (1,4 BENZODIOXAN 6 YL) 3 (4 TERT BUTYLPHENYL)ACRYLAMIDE; N (4 ISOPROPYLPHENYL) 2 (1,2,3,6 TETRAHYDRO 1,3 DIMETHYL 2,6 DIOXO 7H PURIN 7 YL)ACETAMIDE; OMEGA CONOTOXIN; RESINIFERATOXIN; VANILLOID RECEPTOR 1;

AFFECT; ANALGESIA; ANTERIOR CINGULATE; ARTICLE; AVERSIVE BEHAVIOR; AVOIDANCE BEHAVIOR; CHRONIC PAIN; DOPAMINE RELEASE; DOPAMINERGIC NERVE CELL; DRUG EFFICACY; DRUG SELF ADMINISTRATION; ESCAPE BEHAVIOR; HUMAN; HYPERSENSITIVITY; INFLAMMATORY PAIN; MESOLIMBIC DOPAMINERGIC SYSTEM; MOTIVATION; NERVE BLOCK; NEUROPATHIC PAIN; NOCICEPTION; NOCICEPTIVE PAIN; NONHUMAN; NUCLEUS ACCUMBENS; OSTEOARTHRITIC PAIN; OSTEOARTHRITIS; OUTCOME ASSESSMENT; PAIN; PLACE PREFERENCE; POSTOPERATIVE PAIN; REINFORCEMENT; REWARD; VENTRAL TEGMENTUM;

EID: 84875848288     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1111/nyas.12095     Document Type: Article

References (80)

1. Cox, J.J. et al. 2010. Congenital insensitivity to pain: novel SCN9A missense and in-frame deletion mutations. Hum. Mutat. 31: E1670-E1686.
2. Fields, H.L. 2007. Understanding how opioids contribute to reward and analgesia. Reg. Anesth. Pain. Med. 32: 242-246.
3. Fields, H.L. 1999. Pain: an unpleasant topic. Pain S6: S61-S69.
4. Murray, E.A., S.P. Wise & S.E.V. Rhodes. 2011. Neurobiology of Sensation and Reward Frontiers in Neuroscience. J.A. Gottfried, Ed. Boca Raton, FL: CRC Press.
5. Craig, A.D. 2003. Interoception: the sense of the physiological condition of the body. Curr. Opin. Neurobiol. 13: 500-505.
6. King, T. et al. 2009. Unmasking the tonic-aversive state in neuropathic pain. Nat. Neurosci. 12: 1364-1366.
7. Fuchs, P.N. & C.T. McNabb. 2012. The place escape/avoidance paradigm: a novel method to assess nociceptive processing. J. Integr. Neurosci. 11: 61-72.
8. Martin, T.J. & E. Ewan. 2008. Chronic pain alters drug self-administration: implications for addiction and pain mechanisms. Exp. Clin. Psychopharmacol. 16: 357-366.
9. Matthies, B.K. & K.B. Franklin. 1992. Formalin pain is expressed in decerebrate rats but not attenuated by morphine. Pain 51: 199-206.
10. Woolf, C.J. 1984. Long term alterations in the excitability of the flexion reflex produced by peripheral tissue injury in the chronic decerebrate rat. Pain 18: 325-343.
11. King, C.D., D.P. Devine, C.J. Vierck, et al. 2007. Opioid modulation of reflex versus operant responses following stress in the rat. Neuroscience 147: 174-182.
12. Mauderli, A.P., A. Acosta-Rua & C.J. Vierck. 2000. An operant assay of thermal pain in conscious, unrestrained rats. J. Neurosci. Methods 97: 19-29.
13. LaBuda, C.J. & P.N. Fuchs. 2001. Low dose aspirin attenuates escape/avoidance behavior, but does not reduce mechanical hyperalgesia in a rodent model of inflammatory pain. Neurosci. Lett. 304: 137-140.
14. LaBuda, C.J. & P.N. Fuchs. 2000. A behavioral test paradigm to measure the aversive quality of inflammatory and neuropathic pain in rats. Exp. Neurol. 163: 490-494.
15. Neubert, J.K. et al. 2005. Use of a novel thermal operant behavioral assay for characterization of orofacial pain sensitivity. Pain 116: 386-395.
16. Pereira Do Carmo, G., G.W. Stevenson, W.A. Carlezon & S.S. Negus. 2009. Effects of pain- and analgesia-related manipulations on intracranial self-stimulation in rats: further studies on pain-depressed behavior. Pain 144: 170-177.
17. Okun, A. et al. 2011. Transient inflammation-induced ongoing pain is driven by TRPV1 sensitive afferents. Mol. Pain 7: 1-11.
18. Bennett, G.J. 2012. What is spontaneous pain and who has it? J. Pain 13: 921-929.
19. King, T. et al. 2011. Contribution of afferent pathways to nerve injury-induced spontaneous pain and evoked hypersensitivity. Pain 152: 1997-2005.
20. Liu, P. et al. 2011. Ongoing pain in the MIA model of osteoarthritis. Neurosci. Lett. 493: 72-75.
21. Qu, C. et al. 2011. Lesion of the rostral anterior cingulate cortex eliminates the aversiveness of spontaneous neuropathic pain following partial or complete axotomy. Pain 152: 1641-1648.
22. King, T. et al. 2012. Contribution of PKMzeta-dependent and independent amplification to components of experimental neuropathic pain. Pain 153: 1263-1273.
23. Okun, A. et al. 2012. Afferent drive elicits ongoing pain in a model of advanced osteoarthritis. Pain 153: 924-933.
24. Navratilova, E. et al. 2012. Pain relief produces negative reinforcement through activation of mesolimbic reward-valuation circuitry. Proc Natl Acad Sci USA. 109: 20709-20713.
25. Kim, S.H. & J.M. Chung. 1992. An experimental model for peripheral neuropathy produced by segmental spinal nerve ligation in the rat. Pain 50: 355-363.
26. Rauck, R.L., M.S. Wallace, A.W. Burton, et al. 2009. Intrathecal ziconotide for neuropathic pain: a review. Pain Pract. 9: 327-337.
27. Andrieu, G. et al. 2009. The efficacy of intrathecal morphine with or without clonidine for postoperative analgesia after radical prostatectomy. Anesth. Analg. 108: 1954-1957.
28. Burgess, S.E. et al. 2002. Time-dependent descending facilitation from the rostral ventromedial medulla maintains, but does not initiate, neuropathic pain. J. Neurosci. 22: 5129-5136.
29. Brennan, T.J., E.P. Vandermeulen & G.F. Gebhart. 1996. Characterization of a rat model of incisional pain. Pain 64: 493-501.
30. Xu, J. & T.J. Brennan. 2009. Comparison of skin incision vs. skin plus deep tissue incision on ongoing pain and spontaneous activity in dorsal horn neurons. Pain 144: 329-339.
31. Xu, J. & T.J. Brennan. 2010. Guarding pain and spontaneous activity of nociceptors after skin versus skin plus deep tissue incision. Anesthesiology 112: 153-164.
32. Moiniche, S., J.B. Dahl, C.J. Erichsen, et al. 1997. Time course of subjective pain ratings, and wound and leg tenderness after hysterectomy. Acta Anaesthesiol. Scand. 41: 785-789.
33. Chandran, P. et al. 2009. Pharmacological modulation of movement-evoked pain in a rat model of osteoarthritis. Eur. J. Pharmacol. 613: 39-45.
34. Ivanavicius, S.P. et al. 2007. Structural pathology in a rodent model of osteoarthritis is associated with neuropathic pain: increased expression of ATF-3 and pharmacological characterisation. Pain 128: 272-282.
35. Pomonis, J.D. et al. 2005. Development and pharmacological characterization of a rat model of osteoarthritis pain. Pain 114: 339-346.
36. Marker, C.L. & J.D. Pomonis. 2012. The monosodium iodoacetate model of osteoarthritis pain in the rat. Methods Mol. Biol. 851: 239-248.
37. Deshmukh, A.J., G. Panagopoulos, A. Alizadeh, et al. 2011. Intra-articular hip injection: does pain relief correlate with radiographic severity of osteoarthritis? Skeletal. Radiol. 40: 1449-1454.
38. Pavelka, K. 2012. A comparison of the therapeutic efficacy of diclofenac in osteoarthritis: a systematic review of randomised controlled trials. Curr. Med. Res. Opin. 28: 163-178.
39. Lavand'homme, P.M., F. Roelants, H. Waterloos, et al. 2008. An evaluation of the postoperative antihyperalgesic and analgesic effects of intrathecal clonidine administered during elective cesarean delivery. Anesth. Analg. 107: 948-955.
40. Eisenach, J.C., R.L. Rauck & R. Curry. 2003. Intrathecal, but not intravenous adenosine reduces allodynia in patients with neuropathic pain. Pain 105: 65-70.
41. Immke, D.C. & N.R. Gavva. 2006. The TRPV1 receptor and nociception. Semin. Cell Dev. Biol. 17: 582-591.
42. Baron, R. 2009. Neuropathic pain: a clinical perspective. Handb. Exp. Pharmacol. 194: 3-30.
43. Szallasi, A., F. Joo & P.M. Blumberg. 1989. Duration of desensitization and ultrastructural changes in dorsal root ganglia in rats treated with resiniferatoxin, an ultrapotent capsaicin analog. Brain Res. 503: 68-72.
44. Ossipov, M.H., D. Bian, T.P. Malan, Jr., et al. 1999. Lack of involvement of capsaicin-sensitive primary afferents in nerve-ligation injury induced tactile allodynia in rats. Pain 79: 127-133.
45. Geha, P.Y. et al. 2007. Brain activity for spontaneous pain of postherpetic neuralgia and its modulation by lidocaine patch therapy. Pain 128: 88-100.
46. Leknes, S. & I. Tracey. 2008. A common neurobiology for pain and pleasure. Nat. Rev. Neurosci. 9: 314-320.
47. Johansen, J.P., H.L. Fields & B.H. Manning. 2001. The affective component of pain in rodents: direct evidence for a contribution of the anterior cingulate cortex. Proc. Natl. Acad. Sci. USA 98: 8077-8082.
48. Li, X.Y. et al. 2010. Alleviating neuropathic pain hypersensitivity by inhibiting PKMzeta in the anterior cingulate cortex. Science 330: 1400-1404.
49. Tracey, I. 2010. Getting the pain you expect: mechanisms of placebo, nocebo and reappraisal effects in humans. Nat. Med. 16: 1277-1283.
50. Tracey, I. & P.W. Mantyh. 2007. The cerebral signature for pain perception and its modulation. Neuron 55: 377-391.
51. Liu, Z.H., R. Shin & S. Ikemoto. 2008. Dual role of medial A10 dopamine neurons in affective encoding. Neuropsychopharmacology 33: 3010-3020.
52. Zellner, M.R. & R. Ranaldi. 2010. How conditioned stimuli acquire the ability to activate VTA dopamine cells: a proposed neurobiological component of reward-related learning. Neurosci. Biobehav. Rev. 34: 769-780.
53. Soderman, A.R. & E.M. Unterwald. 2008. Cocaine reward and hyperactivity in the rat: sites of mu opioid receptor modulation. Neuroscience 154: 1506-1516.
54. Leknes, S., M. Lee, C. Berna, et al. 2011. Relief as a reward: hedonic and neural responses to safety from pain. PLoS One 6: e17870.
55. Swanson, L.W. 1982. The projections of the ventral tegmental area and adjacent regions: a combined fluorescent retrograde tracer and immunofluorescence study in the rat. Brain Res. Bull. 9: 321-353.
56. Kaplan, G.B., K.A. Leite-Morris, M. Joshi, et al. 2003. Baclofen inhibits opiate-induced conditioned place preference and associated induction of Fos in cortical and limbic regions. Brain Res. 987: 122-125.
57. Moaddab, M., A. Haghparast & M. Hassanpour-Ezatti. 2009. Effects of reversible inactivation of the ventral tegmental area on the acquisition and expression of morphine-induced conditioned place preference in the rat. Behav. Brain Res. 198: 466-471.
58. Schultz, W. 2010. Dopamine signals for reward value and risk: basic and recent data. Behav. Brain Funct. 6: 24.
59. Bajic, D. & K.G. Commons. 2010. Acute noxious stimulation modifies morphine effect in serotonergic but not dopaminergic midbrain areas. Neuroscience 166: 720-729.
60. Allen, K.V., I.S. McGregor, G.E. Hunt, et al. 2003. Regional differences in naloxone modulation of Delta(9)-THC induced Fos expression in rat brain. Neuropharmacology 44: 264-274.
61. Hargreaves, G.A., G.E. Hunt, J.L. Cornish & I.S. McGregor. 2007. High ambient temperature increases 3, 4-methylenedioxymethamphetamine (MDMA, "ecstasy")-induced Fos expression in a region-specific manner. Neuroscience 145: 764-774.
62. Ikemoto, S. 2007. Dopamine reward circuitry: two projection systems from the ventral midbrain to the nucleus accumbens-olfactory tubercle complex. Brain Res. Rev. 56: 27-78.
63. Di Chiara, G. et al. 2004. Dopamine and drug addiction: the nucleus accumbens shell connection. Neuropharmacology 47 (Suppl 1): 227-241.
64. Ritman, M.F., R.A. Wheeler, R.M. Wightman & R.M. Carelli. 2008. Real-time chemical responses in the nucleus accumbens differentiate rewarding and aversive stimuli. Nat. Neurosci. 11: 1376-1377.
65. Pontieri, F.E., G. Tanda & G. Di Chiara. 1995. Intravenous cocaine, morphine, and amphetamine preferentially increase extracellular dopamine in the "shell" as compared with the "core" of the rat nucleus accumbens. Proc. Natl. Acad. Sci. USA 92: 12304-12308.
66. Montague, P.R., B. King-Casas & J.D. Cohen. 2006. Imaging valuation models in human choice. Annu. Rev. Neurosci. 29: 417-448.
67. Platt, M.L. & S.A. Huettel. 2008. Risky business: the neuroeconomics of decision making under uncertainty. Nat. Neurosci. 11: 398-403.
68. O'Doherty, J. et al. 2004. Dissociable roles of ventral and dorsal striatum in instrumental conditioning. Science 304: 452-454.
69. O'Doherty, J.P. 2004. Reward representations and reward-related learning in the human brain: insights from neuroimaging. Curr. Opin. Neurobiol. 14: 769-776.
70. Becerra, L. & D. Borsook. 2008. Signal valence in the nucleus accumbens to pain onset and offset. Eur. J. Pain 12: 866-869.
71. Jarcho, J.M., E.A. Mayer, Z.K. Jiang, et al. 2012. Pain, affective symptoms, and cognitive deficits in patients with cerebral dopamine dysfunction. Pain 153: 744-754.
72. Potvin, S., S. Grignon & S. Marchand. 2009. Human evidence of a supra-spinal modulating role of dopamine on pain perception. Synapse 63: 390-402.
73. Gerdelat-Mas, A. et al. 2007. Levodopa raises objective pain threshold in Parkinson's disease: a RIII reflex study. J. Neurol. Neurosurg. Psychiatr. 78: 1140-1142.
74. Hagelberg, N. et al. 2004. Striatal dopamine D2 receptors in modulation of pain in humans: a review. Eur. J. Pharmacol. 500: 187-192.
75. Wood, P.B. et al. 2007. Fibromyalgia patients show an abnormal dopamine response to pain. Eur. J. Neurosci. 25: 3576-3582.
76. Willoch, F. et al. 2004. Central poststroke pain and reduced opioid receptor binding within pain processing circuitries: a [11C]diprenorphine PET study. Pain 108: 213-220.
77. Wood, P.B., M.F. Glabus, R. Simpson & J.C. Patterson, IInd. 2009. Changes in gray matter density in fibromyalgia: correlation with dopamine metabolism. J. Pain 10: 609-618.
78. Laviolette, S.R., K. Nader & D. van der Kooy. 2002. Motivational state determines the functional role of the mesolimbic dopamine system in the mediation of opiate reward processes. Behav. Brain Res. 129: 17-29.
79. Narita, M. et al. 2005. Direct evidence for the involvement of the mesolimbic kappa-opioid system in the morphine-induced rewarding effect under an inflammatory pain-like state. Neuropsychopharmacology 30: 111-118.
80. Scott, D.J. et al. 2008. Placebo and nocebo effects are defined by opposite opioid and dopaminergic responses. Arch. Gen. Psychiatr. 65: 220-231.